860626 | C8 Dihydroceramide (d18:0/8:0)
N-octanoyl-D-erythro-sphinganine

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C8 Dihydroceramide (d18:0/8:0)
N-octanoyl-D-erythro-sphinganine
CAS Registry Number is a Registered Trademark of the American Chemical Society
C8 Sphinganine
C8 dihydrosphingosine
N-(octanoyl)-sphinganine
Saville JT, McDermott BK, Chin SJ, Fletcher JM, Fuller M. Expanding the clinical utility of glucosylsphingosine for Gaucher disease. J Inherit Metab Dis. 2019 Nov 9. doi: 10.1002/jimd.12192. [Epub ahead of print]
PubMed ID: 31707742- Certificate of Analysis (Lot No. 860626P-5MG-A-011 and 6054PHA011)
- Certificate of Analysis (Lot No. 860626P-5MG-B-011 and 6054PHB011)
- Certificate of Analysis (Lot No. 860626P-5MG-D-011 and 6054PHD011)